Healio Gastroenterology Plays a Role in DDW Twitter Conversation

Issue: June 2015

With a goal of engaging with you, our readers, and the Digestive Disease Week community, Healio Gastroenterology took our peer-tested content to Twitter during the recent meeting in Washington, D.C.

Over the 4 days, we tweeted 192 times, garnering 64,600 impressions. Our links were clicked 166 times and you retweeted us 279 times. Our tweets were favorited 154 times and we engaged in 17 conversations. To see these tweets and many more from the meeting, you can search #DDW15 on Twitter.

Through this interaction, Healio Gastroenterology is happy to announce the winner of a set of SLACK Incorporated gastroenterology textbooks: Christina Tennyson, MD, associate physician at the Brooklyn Heights location of Mount Sinai Hospital in New York. Thank you for being one of the many new followers to our Twitter feed and engaging with us during DDW. We enjoyed your commentary and participation in the celiac disease chat. For great insight to celiac disease in the Twitter community, follow @DoctorTennyson.

If you did not follow our Twitter coverage of DDW, please join us now at Twitter.com/HealioGastro and engage with us on a daily basis, following our links to our online content that will appear in the pages of Healio Gastroenterology.

To catch you up on our coverage, here are the top five Tweets by engagement rate:

1. 6.65% engagement rate (https://twitter.com/HealioGastro/status/599672615708528641)

#Rifaximin is efficacious in the treatment of functional #dyspepsia, particularly for global dyspeptic symptoms, belching & bloating #DDW15
— Gastroenterology (@HealioGastro) May 16, 2015

2. 5.74% engagement rate (https://twitter.com/HealioGastro/status/599888589682548736)

BLOG: Would you like Beethoven with Your #Colonoscopy? #DDW15 http://t.co/Vwjkpoj6Vp
— Gastroenterology (@HealioGastro) May 17, 2015

3. 5.56% engagement rate (https://twitter.com/HealioGastro/status/600427388464459776)

Intragastric balloon produces 'excessive weight loss' in nearly 50% of patients. #DDW15 http://t.co/yh3HDwoDrA
— Gastroenterology (@HealioGastro) May 18, 2015

4. 5.10% engagement rate (https://twitter.com/HealioGastro/status/600783293034946560)

ALLY-2: Daklinza/Sovaldi effective in #HCV patients with #HIV, #cirrhosis -Sherman, @uofcincy http://t.co/P03kPGrv2g
— Gastroenterology (@HealioGastro) May 19, 2015

5. 5.07% engagement rate (https://twitter.com/HealioGastro/status/600279480578351104)

Edlin @WeillCornell Payer restrictions of Hep C treatment contradict medical specialty guidance, are discriminatory, and are illegal. @ddw15
— Gastroenterology (@HealioGastro) May 18, 2015